Management of type 2 diabetes: A handbook for general practice

Type 2 diabetes and mental health

Type 2 diabetes and mental health


Recommendation 

Grade 

References 

Recommended as of:

Routinely monitor people with diabetes for diabetes distress. 

B

1,2

14/11/2024

Providers should consider assessment for symptoms of diabetes distress, depression, anxiety, disordered eating and cognitive capacities using patient-appropriate standardised and validated tools when there is a change in disease, treatment, or life circumstance; including caregivers and family members in this assessment is recommended. 

1,2 

14/11/2024

People with diabetes with any of the following should be referred to a mental health professional and to do a care plan: 

  • significant distress related to diabetes management 
  • persistent fear of hypoglycaemia 
  • psychological insulin resistance 
  • psychiatric disorders (ie depression, anxiety, eating disorders). 

D, Consensus 

1,3 

14/11/2024

Collaborative care by interprofessional teams should be provided for people with diabetes and depression to improve: 

  • depressive symptoms 
  • adherence to antidepressant and non-insulin glucose-lowering medications 
  • glycaemic control*. 

*Glycaemic management 

A, Level 1 

3-6

14/11/2024

Psychosocial interventions should be integrated into diabetes care to improve adaptation to living with diabetes and engagement in self-management, including: 

  • motivational interviewing 
  • cognitive behaviour therapy 
  • acceptance and commitment therapy 
  • stress management strategies 
  • coping skills training 
  • family therapy 
  • case management 
  • mindfulness interventions 

 



A, Level 1A 
A, Level 1A 
A, Level 1 
A, Level 1A 
A, Level 1A 
A, Level 1B 
A, Level 1 

3,4,7-9

 

 

 

 

14/11/2024

People with diabetes can face a number of psychosocial challenges, which can change over the course of their lives with the condition (Figure 1). It is common for people with diabetes to sometimes feel overwhelmed, guilty or frustrated by the considerable burden of self-care and management required by diabetes. They might also feel worried about their current or future diabetes management and health outcomes,10 and can face stigma, discrimination or a lack of understanding from friends or family members about their condition. Timely assessment of the impact of diabetes on people’s mental health can be incorporated into routine clinical reviews and, as a minimum, needs to be aligned to the annual cycle of care.

People with diabetes are more likely to experience other mental health problems:

  • Diabetes has a bidirectional relationship with some psychological conditions, particularly major depression (however, the mechanisms of this relationship are as yet unknown).3
  • Anxiety disorders and disordered eating are more common in people with diabetes.11
  • People with psychotic disorders (eg schizophrenia) have significantly increased rates of type 2 diabetes.11

The main risk factors in type 2 diabetes for cognitive dysfunction, depression and psychological problems are illustrated in figure 2 in the article by Randväli et al.12

Diabetes distress is a clinically recognised emotional response to living with diabetes and the medical, financial and social impacts of diabetes. Other common diabetes-specific psychological responses are fear of hypoglycaemia and psychological insulin resistance (refer below).

Diabetes distress and other psychological conditions can negatively affect health outcomes due to suboptimal self-management and glycaemic outcomes.10,13,14

General practitioners (GPs) also need to be aware that the metabolic effects of some psychotropic medications (eg the antipsychotic medications olanzapine and clozapine15, 16) can increase the complexity of type 2 diabetes management or add additional burdens such as obesity (refer to ‘Managing multimorbidity in people with type 2 diabetes’). 



Figure 1.
Psychosocial challenges experienced by people with diabetes at different phases of life11 

 

Diabetes distress 

Diabetes distress is a condition distinct from other psychological disorders and is estimated to affect 18–45% of people with diabetes.11 Severe diabetes distress is experienced by 20% of people with insulin-treated type 2 diabetes and by 11% of those with non-insulin-treated type 2 diabetes.17

Although some symptoms often overlap with depressive symptoms, diabetes distress is a separate psychological condition that should be assessed for separately (Table 1).18 It is associated with suboptimal diabetes self-care and glycaemic outcomes10,11

Causes of diabetes distress differ between individuals, but are commonly related to the following domains:19 

  • emotional and cognitive distress – for example: 
    • worries about long-term diabetes-related complications 
    • fears about loss of quality of life 
    • guilt, anger, frustration or burnout associated with the ongoing need for care 
  • interpersonal distress – for example: 
    • feeling unsupported or misunderstood by loved ones 
  • regimen or management distress – for example: 
    • difficulty keeping up with dietary recommendations 
    • stress from changes to treatment (eg changing from oral to injectable therapy) 
    • stress related to the need for ongoing glucose self-monitoring 
    • fear associated with reviews of glycated haemoglobin (HbA1c) and not achieving target levels 
  • distress arising from interactions with healthcare professionals – for example: 
    • feeling that treating clinicians do not understand concerns or take them seriously. 

Psychological insulin resistance 

Psychological insulin resistance refers to a person’s strong negative thoughts and feelings about starting, using or intensifying insulin therapy.3

This may be due to fear and anxiety about having to self-administer injections, concerns about insulin and its effects (eg hypoglycaemia or weight gain) or misplaced beliefs (eg that requiring insulin means they have failed to self-manage their diabetes or that the condition has become much more serious). 

The National Diabetes Services Scheme (NDSS) and Diabetes Australia have developed resources to support people starting and using insulin to manage their diabetes: 

Fear of hypoglycaemia 

Experiences of hypoglycaemia, especially severe (requiring assistance) or nocturnal episodes, can be physically dangerous and psychologically traumatic. Some level of concern about hypoglycaemia is adaptive and is a motive to respond to low glucose levels on time. However, fear of hypoglycaemia (extreme fear in response to risk or occurrence of hypoglycaemia) can lead to unhelpful strategies to avoid hypoglycaemia, such as: 

  • maintaining a higher blood glucose level (compensatory hyperglycaemia) 
  • treating perceived symptoms without confirming hypoglycaemia by self-monitoring. 

Left unmanaged, in the long term these behaviours can affect glycaemic outcomes and reduce quality of life. Technology such as continuous glucose monitoring or flash monitoring (often with alarms developed for hypoglycaemia) may help people who are averse to finger pricking. 

Other psychological and psychiatric conditions 

Increased understanding of the psychological aspects of the person with diabetes would allow clinicians to formulate strategies focusing on improvements in diabetes outcomes and reducing disease burden.20 Other mental health conditions that can affect or are affected by diabetes include major depression, schizophrenia spectrum disorders, bipolar disorder, eating disorders and anxiety.3

Depression and diabetes are interlinked with a higher risk of developing diabetes in people who have a history of or current depression that is compounded if the person is overweight or obese and with a family history of depression. 

GPs play an essential role in assessing and supporting people with diabetes and mental health conditions by providing care and serving as the pivotal point for referral to appropriate mental health professionals that form the multidisciplinary care team. Collaborative care should be considered for people with diabetes and depression. Routine interval assessment for the presence of these conditions, particularly anxiety and depression, may be incorporated into the annual diabetes cycles of care, but also be provided opportunistically. Validated tools may support comparative interval assessment. Avoidance of stigmatisation and using appropriate language when managing people living with diabetes are foundational on building a trusted therapeutic care model.21

Medications used for the management of depression, particularly selective serotonin reuptake inhibitors (SSRIs) have been shown to improve glycaemic management. Any medication used, particularly antipsychotic agents when used in at-risk individuals (eg history of gestational diabetes, family history of diabetes, presence of visceral obesity), may need to be evaluated for risks of inducing hyperglycaemia and diabetes.3 

Given the high prevalence of diabetes distress and other mental health conditions, people with type 2 diabetes should be assessed at the initial visit, at periodic intervals (eg at annual review) and when there is a change in condition, treatment or life circumstance. It is recommended to assess for diabetes distress, depression, anxiety, disordered eating and cognitive capacities.2,11 GPs may decide to prioritise assessment of conditions according to each individual’s phase of living with diabetes (Figure 1); for example, assessing for cognitive impairment in older people (see ‘Dementia, cognitive decline and hearing impairment’ in the ‘Managing risks and other impacts of type 2 diabetes’ section). 

Information and guidance about how to have conversations with people about diabetes and mental health, including tips for using the screening tools detailed below, can be found in the NDSS publication Diabetes and emotional health: A handbook for health professionals supporting adults with type 1 or type 2 diabetes

If necessary, people should be referred to a mental health professional, preferably one with experience in psychosocial care for people with diabetes (Box 1).11 

Screening 

GPs can identify clinically significant diabetes distress and other mental health issues by having ongoing conversations with people about how they feel about their diabetes. Informal, open-ended questions can help get a sense of what the likely problems are for a person. For example: 

  • ‘How is diabetes bothering you at the moment?’ 
  • ‘What is the most difficult part of living with diabetes for you?’ 

For more information, refer to Diabetes Australia’s position statement Our language matters: Improving communication with and about people with diabetes22 and the American Diabetes Association article ‘The use of language in diabetes care and education’.23 These publications provide recommendations for the language healthcare professionals and others should use when discussing diabetes through spoken or written words. 

If indicated, standardised tools can then be used to further assess for symptoms. Tools for assessing diabetes distress (Table 1) are freely available. 

The Patient Health Questionnaire (PHQ)-2 or PHQ-9 can be used to screen for depressive symptoms. 

  • A PHQ-2 total score of ≥3 in a person who is not currently receiving treatment for depression requires assessment with the PHQ-9.24
  • PHQ-9 scores are interpreted as follows:
    • 0–4: no depressive symptoms (or a minimal level) 
    • 5–9: mild depressive symptoms – these people will benefit from watchful waiting 
    • 10–27: moderate-to-severe depressive symptoms – these people will benefit from a more active method of intervention. 

If depression is suspected from the PHQ-9, a formal clinical assessment for depression and management should be undertaken. 

In addition, the Depression, Anxiety and Stress Scale (DASS) may be helpful as an assessment tool for people with diabetes and mental health symptoms. The Kessler Psychological Distress Scale (K10) is widely recommended as a simple measure of psychological distress and is often used by GPs because it is available in consultation software.25 

To effectively use screening tools, GPs should be mindful of the person’s health literacy, being sure to explain what the tool is for and how it can help the person receive individualised support. 

Table 1. Tools to assess diabetes distress in people with diabetes 

Tool 

Scoring 

Validated population 

Problem Areas in Diabetes (PAID)26 

Patients receive a total score out of 100; scores ≥40 indicate severe diabetes distress 

Adults with type 1 and type 2 diabetes 

Paediatric, teen and parent versions are also available 

Diabetes Distress Scale (DDS)27,28 

A 17-item questionnaire measuring diabetes-specific distress in four domains: emotional burden, interpersonal distress, physician-related distress and regimen-related distress 

A mean score ≥3 in any domain indicates ‘high’ distress 

Adults with type 1 and type 2 diabetes 


Management 

The 7A’s model (see below) is a practical way to structure mental health care for people with diabetes, adapted from the 5A’s model often used for counselling in other areas (eg smoking cessation, obesity).18 The 7A’s model encourages healthcare professionals to: 

  • be aware that people with diabetes might have emotional or mental health problems 
  • ask about these problems, using open-ended questions 
  • assess for emotional or mental health problems using a validated tool 
  • advise people about identified problems 
  • assist them with developing an achievable action plan 
  • assign care, where appropriate, to another healthcare professional (eg psychologist, diabetes specialist or credentialled diabetes educator) 
  • arrange follow-up care. 

More information about the 7A’s model can be found in the NDSS publication Diabetes and emotional health: A handbook for health professionals supporting adults with type 1 or type 2 diabetes.18 

Versions of this model to specifically manage diabetes distress, fear of hypoglycaemia, psychological barriers to insulin use, depression, anxiety disorders and eating disorders can be found in the NDSS handbook summary cards.17 

Management of mental health problems should be offered within diabetes care settings and general practices, using current supported care such as mental health care planning. GP mental health treatment plans provide a structured framework for GPs to undertake assessment, early intervention and management of people with a mental illness.29 

For more information, refer to The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders, which includes: 

  • table 9: Pharmacological treatment based on clinical profile 
  • table 10: Classes of antidepressants 
  • figure 26: Management of major depression.30 

Box 1. Referring people with diabetes to a mental health provider 

The listed conditions and symptoms are suggestions of an underlying possible psychosocial or mental health issue that needs exploration BEFORE referral, if required. 

People with diabetes who display any of the following should be referred to a mental health provider:11 

  • diabetes distress and impaired self-care despite tailored diabetes education 
  • positive screen for depressive symptoms on a validated screening tool 
  • symptoms or signs of disordered eating behaviour, an eating disorder or disrupted patterns of eating 
  • deliberate omission of insulin or oral medication to cause weight loss 
  • positive screen for anxiety or fear of hypoglycaemia on a validated screening tool 
  • positive screen for cognitive impairment 
  • declining or impaired ability to self-care. 

People should be referred before undergoing bariatric surgery, and after, if assessment reveals an ongoing need for adjustment support.11 

The NDSS has a range of resources regarding emotional health and diabetes

The NDSS and Diabetes Australia have developed resources to support people starting and using insulin to manage their diabetes (see ‘Psychological insulin resistance’): 

The NDSS and Diabetes Australia have published Diabetes and emotional health: A handbook for health professionals supporting adults with type 1 or type 2 diabetes

The Royal Australian and New Zealand College of Psychiatrists has developed clinical practice guidelines for mood disorders

  1. McMorrow R, Hunter B, Hendrieckx C, et al. Effect of routinely assessing and addressing depression and diabetes distress on clinical outcomes among adults with type 2 diabetes: A systematic review. BMJ Open 2022;12(5):e054650. doi: 10.1136/bmjopen-2021-054650.
  2. American Diabetes Association Professional Practice Committee. Standards of care in diabetes – 2024. Diabetes Care 2024;47(Suppl 1):S1–322.
  3. Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Diabetes and Mental Health 2023 Update. Can J Diabetes 2018;42(Suppl 1):S308–44.
  4. van der Feltz-Cornelis C, Allen SF, Holt RIG, Roberts R, Nouwen A, Sartorius N. Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: Systematic review and meta-analysis. Brain Behav 2021;11(2):e01981. doi: 10.1002/brb3.1981.
  5. Diaz Bustamante L, Ghattas KN, Ilyas S, Al-Refai R, Maharjan R, Khan S. Does treatment for depression with collaborative care improve the glycemic levels in diabetic patients with depression? A systematic review. Cureus 2020;12(9):e10551. doi: 10.7759%2Fcureus.10551.
  6. Franquez RT, de Souza IM, Bergamaschi CC. Interventions for depression and anxiety among people with diabetes mellitus: Review of systematic reviews. PLoS One 2023;18(2):e0281376. doi: 10.1371/journal.pone.0281376.
  7. Ngan HY, Chong YY, Chien WT. Effects of mindfulness- and acceptance-based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: Systematic review and meta-analysis. Diabet Med 2021;38(4):e14525. doi: 10.1111/dme.14525.
  8. Berhe KK, Gebru HB, Kahsay HB. Effect of motivational interviewing intervention on HgbA1C and depression in people with type 2 diabetes mellitus (systematic review and meta-analysis). PLoS One 2020;15(10):e0240839. doi: 10.1371/journal.pone.0240839.
  9. Fisher V, Li WW, Malabu U. The effectiveness of mindfulness-based stress reduction (MBSR) on the mental health, HbA1C, and mindfulness of diabetes patients: A systematic review and meta-analysis of randomised controlled trials. Appl Psychol Health Well-Being 2023;15(4):1733–49. doi: 10.1111/aphw.12441.
  10. Fisher L, Gonzalez JS, Polonsky WH. The confusing tale of depression and distress in patients with diabetes: A call for greater clarity and precision. Diabet Med 2014;31(7):764–72. doi: 10.1111/dme.12428.
  11. Young-Hyman D, de Groot M, Hill-Briggs F, Gonzalez JS, Hood K, Peyrot M. Psychosocial care for people with diabetes: A position statement of the American Diabetes Association. Diabetes Care 2016;39(12):2126–40. doi: 10.2337/dc16-2053.
  12. Randväli M, Toomsoo T, Šteinmiller J. The main risk factors in type 2 diabetes for cognitive dysfunction, depression, and psychosocial problems: A systematic review. Diabetology (Basel) 2024;5(1):40–59. doi: 10.3390/diabetology5010004.
  13. Nanayakkara N, Pease A, Ranasinha S, et al. Depression and diabetes distress in adults with type 2 diabetes: Results from the Australian National Diabetes Audit (ANDA) 2016. Sci Rep 2018;8(1):7846. doi: 10.1038/s41598-018-26138-5.
  14. Fisher L, Mullan JT, Arean P, Glasgow RE, Hessler D, Masharani U. Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses. Diabetes Care 2010;33(1):23–28. doi: 10.2337/dc09-1238.
  15. Hirsch L, Yang J, Bresee L, Jette N, Patten S, Pringsheim T. Second-generation antipsychotics and metabolic side effects: A systematic review of population-based studies. Drug Saf 2017;40(9):771–81. doi: 10.1007/s40264-017-0543-0.
  16. Proietto J. Diabetes and antipsychotic drugs. Aust Prescr 2004;27(5):118–19. doi: 10.18773/austprescr.2004.098.
  17. Ventura AD, Browne JL, Holmes-Truscott E, Hendrieckx C, Pouwer F, Speight J. Diabetes MILES-2: 2016 survey report. Australian Centre for Behavioural Research in Diabetes, 2016 [Accessed 10 September 2024].
  18. Hendrieckx C, Halliday JA, Beeney L, Speight J. Diabetes and emotional health: A practical guide for health professionals supporting adults with type 1 or type 2 diabetes. 2nd edn. National Diabetes Services Scheme, 2020 [Accessed 18 September 2024].
  19. Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: Development of the diabetes distress scale. Diabetes Care 2005;28(3):626–31. doi: 10.2337/diacare.28.3.626.
  20. Kalra S, Jena BN, Yeravdekar R. Emotional and psychological needs of people with diabetes. Indian J Endocrinol Metab 2018;22(5):696–704. doi: 10.4103/ijem.IJEM_579_17.
  21. de Groot M. Diabetes and depression: Strategies to address a common comorbidity within the primary care context. Am J Med Open 2023;9:100039. doi: 10.4103/ijem.IJEM_579_17.
  22. Diabetes Australia. Our language matters: Improving communication with and about people with diabetes. [Position statement] Diabetes Australia, 2021 [Accessed 10 September 2024].
  23. Dickinson JK, Guzman SJ, Maryniuk MD, et al. The use of language in diabetes care and education. Diabetes Care 2017;40(12):1790–99. doi: 10.2337/dci17-0041.
  24. Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: Validity of a two-item depression screener. Med Care 2003;41(11):1284–92. doi: 10.1097/01.MLR.0000093487.78664.3C.
  25. Black Dog Institue. K10 [Accessed 10 September 2024].
  26. Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care 1995;18(6):754–60. doi: 10.2337/diacare.18.6.754.
  27. Fisher L, Glasgow RE, Mullan JT, Skaff MM, Polonsky WH. Development of a brief diabetes distress screening instrument. Ann Fam Med 2008;6(3):246–52. doi: 10.2337/diacare.18.6.754.
  28. Fisher L, Hessler DM, Polonsky WH, Mullan J. When is diabetes distress clinically meaningful? Establishing cut points for the Diabetes Distress Scale. Diabetes Care 2012;35(2):259–64. doi: 10.2337/dc11-1572.
  29. General Practice Mental Health Standards Collaboration (GPMHSC). GP mental health treatment plan [Accessed 10 September 2024].
  30. Malhi GS, Bell E, Bassett D, et al. The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders. Aust N Z J Psychiatry 2021;55(1):7–117. doi: 10.1177/0004867420979353.
This event attracts CPD points and can be self recorded

Did you know you can now log your CPD with a click of a button?

Create Quick log


 

Advertising